לבטיראצטם דקסל 250 ישראל - עברית - Ministry of Health

לבטיראצטם דקסל 250

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 250 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם דקסל 500 ישראל - עברית - Ministry of Health

לבטיראצטם דקסל 500

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 500 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם דקסל 750 ישראל - עברית - Ministry of Health

לבטיראצטם דקסל 750

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 750 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

לבטיראצטם דקסל 1000 ישראל - עברית - Ministry of Health

לבטיראצטם דקסל 1000

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 1000 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

פראמול פלוס ישראל - עברית - Ministry of Health

פראמול פלוס

dexcel ltd, israel - caffeine; paracetamol - קפליות - paracetamol 500 mg; caffeine 50 mg - paracetamol - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.

פריו-צ'יפ ישראל - עברית - Ministry of Health

פריו-צ'יפ

dexcel pharma technologies ltd - chlorhexidine digluconate - שבב - chlorhexidine digluconate 2.5 mg - chlorhexidine - chlorhexidine - the perio- chip is indicated for reduction and/or elimination of pathogenic periodontal pocket microbiota, delaying and/or arresting recolonization of the subgingival microflora, reduction and/or elimination of inflammatory lesions in the periodontal pockets, and as an adjunct to mechanical treatment in periodontitis.

זרידקס 150 ישראל - עברית - Ministry of Health

זרידקס 150

dexcel ltd, israel - ranitidine as hydrochloride - טבליה - ranitidine as hydrochloride 150 mg - ranitidine - ranitidine - for the treatment of duodenal ulcer, benign gastric ulcer, oesophageal reflux disease and ulcers associated with the use of non-steroidal anti-inflammatory agents. for the prophylaxis of haemorrhage from stress ulceration.

זרידקס 300 ישראל - עברית - Ministry of Health

זרידקס 300

dexcel ltd, israel - ranitidine as hydrochloride - קפליות - ranitidine as hydrochloride 300 mg - ranitidine - ranitidine - treatment of duodenal ulcer and beingn gastric ulcer, esophageal reflux disease, peptic ulcers associated with the use of non-steroidal anti-inflammatory agent (nsaids). prophylaxis of gastrointestinal hemorrhage from stress ulceration.

אומפרדקס קפליות 20 מג ישראל - עברית - Ministry of Health

אומפרדקס קפליות 20 מג

dexcel ltd, israel - omeprazole - קפליות - omeprazole 20 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.